Letter to the Editor

PCC
Brain Injuries, Illness, and Treatment in Sports
Letter to the Editor

October 2, 2025

In their letter to the editor, the authors discuss the need for sports psychiatry and neurology to be viewed as a central part of the sports medicine field.
,
PCC
Complicated Grief: Is There a Role for Naltrexone?
Letter to the Editor

September 23, 2025

The authors discuss prolonged grief disorder and the use of medications like naltrexone as a potential treatment.
,
PCC
Knowledge of ECT for Catatonia
Letter to the Editor

September 11, 2025

The authors comment on a recent study by Kaur et al assessing what internists and neurologists know about catatonia.
,
PCC
Knowledge of Catatonia: Reply to Espinoza and Kellner
Letter to the Editor

September 11, 2025

The authors reply to a letter to the editor commenting on their article.
, , , et al
JCP
Misleading Labeling of S-Methadone as a Novel N-Methyl-D-Aspartate Receptor Antagonist
Letter to the Editor

September 8, 2025

The authors comment on a recent study by Fava et al showing clinical evidence for a long-term antidepressant effect of esmethadone.
,
JCP
Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant: Reply to Ferré and Michaelides
Letter to the Editor

September 8, 2025

The authors reply to Ferré and Michaelides’ letter commenting on their recent study of long-term esmethadone treatment in MDD.
, , , et al
JCP
Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al
Letter to the Editor

September 1, 2025

The authors reply to a letter by Modesto-Lowe et al regarding their survey of psychedelic practitioners’ views on psychological support.
, , , et al
JCP
Toward Consensus in Psychedelic-Assisted Therapy: The Critical Role of Psychotherapeutic Support
Letter to the Editor

September 1, 2025

A recent survey examining psychedelic practitioners’ views on psychological support in psychedelic-assisted therapy is discussed.
, ,
JCP
Suicide Risk among Patients with Bipolar Disorder: Sleep Disruption versus Benzodiazepine Use
Letter to the Editor

July 28, 2025

The authors comment on a recent study by Saulnier et al of benzodiazepines and suicide among Veterans with bipolar disorder.
,
PCC
Reversible Cerebral Vasoconstriction Syndrome and Marijuana
Letter to the Editor

July 22, 2025

The authors raise awareness of a potential complication of extensive marijuana use.
, ,
PCC
Onco-Psychopharmacology: Is Mirtazapine a Catholicon?
Letter to the Editor

June 24, 2025

The author discusses the role of mirtazapine in the treatment of depression in patients with cancer.
PCC
Community-Based Alternatives in Behavioral Crisis Transport
Letter to the Editor

June 12, 2025

Law enforcement transport for individuals in behavioral health crises results in significant financial costs and psychological trauma, reinforcing criminalization and stigma while worsening mental health conditions.
,
JCP
Erecting Barriers to Suicide by Removing Barriers to Science
Letter to the Editor

April 30, 2025

The authors comment on the implications of a recent NSF communication warning researchers about the use of certain terms in grant proposals and publications made possible with government funding.
, , , et al
PCC
Revisiting Ayahuasca: Vine of the Soul of the Amazon
Letter to the Editor

March 18, 2025

The authors comment on a case report previously published in the PCC describing psychosis and ayahuasca use and discuss the need for further research given its increased usage worldwide.
,
PCC
Cannabis Withdrawal Psychosis
Letter to the Editor

March 13, 2025

Dr Gorelick comments on a case report recently published in the PCC.
PCC
Cannabis Withdrawal Psychosis: Reply to Gorelick
Letter to the Editor

March 13, 2025

The authors reply to a letter to the editor commenting on their case report.
,
PCC
Parenting Young Adults With ADHD
Letter to the Editor

February 13, 2025

The authors explore the role of parental involvement in supporting young adults with ADHD.
, ,
JCP
The Need for Clinical Guidance on Ketamine/Esketamine Use in Clinical Settings
Letter to the Editor

February 5, 2025

The authors comment on a recent study by Santucci et al.
,
JCP
Opioid Use Disorder in Sexually and Gender Diverse Populations: Can We Do Better?
Letter to the Editor

February 3, 2025

The authors respond to a recent JCP article by McDowell and colleagues.
, ,
PCC
Letter to the Editor

December 10, 2024

, , , et al
JCP
Mental Health Assessment and Psychosocial Intervention in Maternal-Fetal Interventions
Letter to the Editor

November 18, 2024

In discussing a recent JCP letter to the editor, Akerson et al recommend that centers for fetal diagnosis and treatment include a social worker who can provide psychosocial assessment,...
, , , et al
JCP
Clarification Regarding the Psychiatrist’s Role—Reply to Akerson et al
Letter to the Editor

November 18, 2024

The authors respond to a letter by Akerson et al.
, , , et al
PCC
Is Bariatric Surgery an Antidepressant?
Letter to the Editor

October 29, 2024

The effect of bariatric surgery on mood disorders is uncertain. Read on to find out more.
JCP
Detecting Misuse of Prescription Opioids
Letter to the Editor

October 21, 2024

The authors discuss the difficulty in screening for opioid misuse and the need for clinicians to gain confidence in initiating difficult discussions with patients on long-term opioid treatment.
, ,

Watch the New PsychCase360

Explore two real-world schizophrenia cases
Promotional banner for a video titled “Choosing the Right LAI for Patients With Schizophrenia” featuring headshots of Roueen Rafeyan, MD, and Melissa Vitale, PMHNP, with a “Watch Now” button.

Subscribe to read
more articles

Subscribe